These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 6094387)

  • 1. An enterovirus-induced murine model of an acute dilated-type cardiomyopathy.
    Reyes MP; Smith FE; Lerner AM
    Intervirology; 1984; 22(3):146-55. PubMed ID: 6094387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coxsackievirus B3 induces T regulatory cells, which inhibit cardiomyopathy in tumor necrosis factor-alpha transgenic mice.
    Huber SA; Feldman AM; Sartini D
    Circ Res; 2006 Nov; 99(10):1109-16. PubMed ID: 17038643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo significance of T cells in the development of Coxsackievirus B3 myocarditis in mice. Immature but antigen-specific T cells aggravate cardiac injury.
    Kishimoto C; Abelmann WH
    Circ Res; 1990 Sep; 67(3):589-98. PubMed ID: 1697791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular and molecular bases for the immunopathology of the myocardial cell damage involved in acute viral myocarditis with special reference to dilated cardiomyopathy.
    Seko Y; Yamazaki T; Shinkai Y; Yagita H; Okumura K; Naito S; Imataka K; Fujii J; Yazaki Y
    Jpn Circ J; 1992 Oct; 56(10):1062-72. PubMed ID: 1331556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ubiquitin-like protein ISG15 (interferon-stimulated gene of 15 kDa) in host defense against heart failure in a mouse model of virus-induced cardiomyopathy.
    Rahnefeld A; Klingel K; Schuermann A; Diny NL; Althof N; Lindner A; Bleienheuft P; Savvatis K; Respondek D; Opitz E; Ketscher L; Sauter M; Seifert U; Tschöpe C; Poller W; Knobeloch KP; Voigt A
    Circulation; 2014 Oct; 130(18):1589-600. PubMed ID: 25165091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of sensitized T-cells in myocarditis and dilated cardiomyopathy.
    Schwimmbeck PL; Badorff C; Rohn G; Schulze K; Schultheiss HP
    Int J Cardiol; 1996 May; 54(2):117-25. PubMed ID: 8803675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modification of exercise-aggravated coxsackievirus B3 murine myocarditis by T lymphocyte suppression in an inbred model.
    Cabinian AE; Kiel RJ; Smith F; Ho KL; Khatib R; Reyes MP
    J Lab Clin Med; 1990 Apr; 115(4):454-62. PubMed ID: 2157783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysis of infected myofibers by coxsackievirus B-3-immune T lymphocytes.
    Huber SA; Job LP; Woodruff JF
    Am J Pathol; 1980 Mar; 98(3):681-94. PubMed ID: 6244737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular matrix remodeling in coxsackievirus B3 myocarditis.
    Kishimoto C; Kitazawa M; Hiraoka Y; Takada H
    Clin Immunol Immunopathol; 1997 Oct; 85(1):47-55. PubMed ID: 9325069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-22-producing Th22 cells play a protective role in CVB3-induced chronic myocarditis and dilated cardiomyopathy by inhibiting myocardial fibrosis.
    Guo Y; Wu W; Cen Z; Li X; Kong Q; Zhou Q
    Virol J; 2014 Dec; 11():230. PubMed ID: 25547181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of cytotoxic T lymphocytes during coxsackievirus tb-3 infection. II. Characterization of effector cells and demonstration cytotoxicity against viral-infected myofibers1.
    Wong CY; Woodruff JJ; Woodruff JF
    J Immunol; 1977 Apr; 118(4):1165-9. PubMed ID: 300400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine profiles in heart, spleen, and thymus during the acute stage of experimental coxsackievirus B3-induced chronic myocarditis.
    Schmidtke M; Glück B; Merkle I; Hofmann P; Stelzner A; Gemsa D
    J Med Virol; 2000 Aug; 61(4):518-26. PubMed ID: 10897072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual functions of murine gammadelta cells in inflammation and autoimmunity in coxsackievirus B3-induced myocarditis: role of Vgamma1+ and Vgamma4+ cells.
    Huber SA; Born W; O'Brien R
    Microbes Infect; 2005 Mar; 7(3):537-43. PubMed ID: 15777711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of in vivo administration of anti-B7-1/B7-2 monoclonal antibodies on the survival of mice with chronic ongoing myocarditis caused by Coxsackievirus B3.
    Seko Y; Takahashi N; Yagita H; Okumura K; Azuma M; Yazaki Y
    J Pathol; 1999 May; 188(1):107-12. PubMed ID: 10398149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dilated cardiomyopathy. An analysis of the viral-immunological theory].
    Aleksandrova LZ; Bakhov NI; Osipov SG; Naumov VG; Titov VN
    Ter Arkh; 1985; 57(4):136-40. PubMed ID: 2990061
    [No Abstract]   [Full Text] [Related]  

  • 16. TRIF is a critical survival factor in viral cardiomyopathy.
    Riad A; Westermann D; Zietsch C; Savvatis K; Becher PM; Bereswill S; Heimesaat MM; Lettau O; Lassner D; Dörner A; Poller W; Busch M; Felix SB; Schultheiss HP; Tschöpe C
    J Immunol; 2011 Feb; 186(4):2561-70. PubMed ID: 21239721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mouse model of dilated-type cardiomyopathy due to coxsackievirus B3.
    Reyes MP; Ho KL; Smith F; Lerner AM
    J Infect Dis; 1981 Sep; 144(3):232-6. PubMed ID: 6268714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of pre-existing coxsackievirus B4 myocardial disease on the expression of coxsackievirus B3 myocarditis.
    Khatib R; Reyes MP; Khatib G; Giraldo A
    Can J Cardiol; 1993 Jun; 9(5):444-7. PubMed ID: 8394194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of B lymphocytes in coxsackievirus B3 infection.
    Mena I; Perry CM; Harkins S; Rodriguez F; Gebhard J; Whitton JL
    Am J Pathol; 1999 Oct; 155(4):1205-15. PubMed ID: 10514403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunological mechanisms in the pathogenesis of coxsackievirus infection].
    Bocharov EF; Shestenko OP
    Vopr Virusol; 1984; 29(5):516-21. PubMed ID: 6151318
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.